Načítá se...
Nanotechnology for Treatment of Glioblastoma Multiforme
Glioblastoma multiforme (GBM), a grade IV astrocytoma as defined by the World Health Organization (WHO) criteria, is the most common primary central nervous system tumor in adults. After treatment with the current standard of care consisting of surgical resection, concurrent temozolomide (TMZ), and...
Uloženo v:
| Vydáno v: | J Transl Int Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sciendo
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6231306/ https://ncbi.nlm.nih.gov/pubmed/30425948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/jtim-2018-0025 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|